Dr. Reddy's Laboratories Limited
RDY
$13.67
-$0.12-0.87%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 666.99M | 668.18M | 641.44M | 639.78M | 668.92M |
| Total Depreciation and Amortization | 211.62M | 201.61M | 193.71M | 183.13M | 181.51M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 32.17M | 33.70M | -7.05M | 11.93M | -34.47M |
| Change in Net Operating Assets | -296.12M | -357.93M | -397.94M | -426.14M | -301.65M |
| Cash from Operations | 614.66M | 545.56M | 430.17M | 408.70M | 514.30M |
| Capital Expenditure | -343.85M | -324.94M | -299.57M | -260.46M | -215.05M |
| Sale of Property, Plant, and Equipment | 4.09M | 6.12M | 6.87M | 11.85M | 14.99M |
| Cash Acquisitions | -633.24M | -633.24M | -614.12M | -614.12M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 302.79M | 263.39M | 235.12M | 61.27M | -428.36M |
| Cash from Investing | -670.22M | -688.68M | -671.70M | -801.46M | -628.42M |
| Total Debt Issued | 13.99B | 24.49B | 29.76B | 33.05B | 16.06B |
| Total Debt Repaid | -1.32B | -1.29B | -1.31B | -304.00M | -456.00M |
| Issuance of Common Stock | 370.00M | 193.00M | 213.00M | 197.00M | 745.00M |
| Repurchase of Common Stock | -1.39B | -1.39B | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -79.53M | -79.53M | -79.53M | -79.53M | -80.41M |
| Other Financing Activities | 3.17B | 3.57B | 3.75B | 4.16B | -2.45B |
| Cash from Financing | 100.59M | 229.02M | 307.75M | 364.22M | 86.31M |
| Foreign Exchange rate Adjustments | 4.45M | 2.59M | -912.80K | 1.08M | 556.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 49.48M | 88.49M | 65.30M | -27.46M | -27.25M |